Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.58 |
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.53 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.51 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.51 |
| ▸ | F7 | P08709 | 5/20 | 0.46 |
| ▸ | F3 | P13726 | 5/20 | 0.46 |
| ▸ | PPARG | P37231 | 3/20 | 0.46 |
| ▸ | PPARD | Q03181 | 3/20 | 0.46 |
| ▸ | PPARA | Q07869 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4444402 | 1.00 | ALDH1A1 (0.58) | ALDH1A1LMNAEPHX2TSHRCYP3A4 | |
| SCHEMBL9003288 | 1.00 | ALDH1A1 (0.58) | ALDH1A1LMNAEPHX2TSHRCYP3A4 | |
| SCHEMBL14241681 | 0.98 | ALDH1A1 (0.56) | ALDH1A1LMNAEPHX2TSHRCYP3A4 | |
| SCHEMBL15634237 | 0.98 | ALDH1A1 (0.56) | ALDH1A1LMNAEPHX2TSHRCYP3A4 | |
| SCHEMBL14166705 | 0.98 | ALDH1A1 (0.56) | ALDH1A1LMNAEPHX2TSHRCYP3A4 | |
| SCHEMBL9975540 | 0.91 | NR1I2 (0.53) | ALDH1A1EPHX2TSHRCYP3A4ALOX15 | |
| SCHEMBL17709725 | 0.91 | ALDH1A1 (0.63) | ALDH1A1LMNAEPHX2TSHRCYP3A4 | |
| SCHEMBL17709720 | 0.91 | ALDH1A1 (0.63) | ALDH1A1LMNAEPHX2TSHRCYP3A4 | |
| SCHEMBL17709726 | 0.91 | ALDH1A1 (0.63) | ALDH1A1LMNAEPHX2TSHRCYP3A4 | |
| SCHEMBL17709719 | 0.91 | ALDH1A1 (0.63) | ALDH1A1LMNAEPHX2TSHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10906861-B2 | Methods of making organic compounds by metathesis | WILMAR TRADING PTE LTD (SG) | 2021-02-02 | — | — | US | disclosed |
| EP-3281931-A1 | METHODS OF MAKING ORGANIC COMPOUNDS BY METATHESIS | Elevance Renewable Sciences, Inc. (US) | 2018-02-14 | — | — | EP | disclosed |
| US-20150307438-A1 | Methods of Making Organic Compounds by Metathesis | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2015-10-29 | — | — | US | disclosed |
| US-9120742-B2 | Methods of making organic compounds by metathesis | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2015-09-01 | — | — | US | disclosed |
| US-20090264672-A1 | METHODS OF MAKING ORGANIC COMPOUNDS BY METATHESIS | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2009-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264672-A1 | METHODS OF MAKING ORGANIC COMPOUNDS BY METATHESIS | COASY, FASN, HAO2 | ALDH1A1 97/4885LMNA 1404/4885EPHX2 148/4885 |
| US-10906861-B2 | Methods of making organic compounds by metathesis | COASY, FASN, HAO2 | ALDH1A1 97/4885LMNA 1404/4885EPHX2 148/4885 |
| US-20150307438-A1 | Methods of Making Organic Compounds by Metathesis | COASY, FASN, HAO2 | ALDH1A1 97/4885LMNA 1404/4885EPHX2 148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.